I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Neutralizing activity against Omicron BA.5 after tixagevima..:
Jinyoung Yang
;
Gunho Won
;
Jin Yang Baek
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1139980/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1139980
RT Journal T1
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ebbfff69c33a4390ac032a4264dd855b&Exemplar=1&LAN=DE A1 Jinyoung Yang A1 Gunho Won A1 Jin Yang Baek A1 Young Ho Lee A1 Haein Kim A1 Kyungmin Huh A1 Sun Young Cho A1 Cheol-In Kang A1 Doo Ryeon Chung A1 Kyong Ran Peck A1 Kyo Won Lee A1 Jae Berm Park A1 Sang Eun Yoon A1 Seok Jin Kim A1 Won Seog Kim A1 Min Su Yim A1 Kwangwook Kim A1 Seokhwan Hyeon A1 Byung Chul Kim A1 Yoo-kyung Lee A1 Jae-Hoon Ko PB Frontiers Media S.A. YR 2023 K1 COVID-19 K1 SARS-CoV-2 K1 Evusheld K1 neutralizing antibody K1 BA.5 variant K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1139980/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1139980 DO https://doi.org/10.3389/fimmu.2023.1139980 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)